Erica L. Mayer, MD, MPH, of Dana Farber Cancer Institute in Boston, Massachusetts, recently attended the San Antonio Breast Cancer Symposium in Texas. In this podcast, she draws attention to various studies that she found particularly compelling. Some of these highlights include:
An update from a drug therapy clinical trial, the TH3RESA study, for HER2+ breast cancer [1:45]
Studies using liquid biopsies, which represent a new technology that can analyze a tumor with a small blood sample [4:35]
A large clinical trial looking at complications of mastectomy for treating early-stage breast cancer [7:55]
This is a pre-recorded audio podcast and it can be listened to online or downloaded to your computer. For more information, visit the Cancer.Net podcast page.
